104 related articles for article (PubMed ID: 24457399)
1. The validity of current guidelines regarding surgical management of patients with gastric neuroendocrine neoplasms type 1: a report of a series of seven patients.
Boutzios G; Griniatsos J; Dimitriou N; Zilos A; Antoniou S; Felekouras E; Kaltsas G
Hormones (Athens); 2013; 12(4):517-21. PubMed ID: 24457399
[TBL] [Abstract][Full Text] [Related]
2. Recurrent gastric neuroendocrine tumors treated with total gastrectomy.
Jung M; Kim JW; Jang JY; Chang YW; Park SH; Kim YH; Kim YW
World J Gastroenterol; 2015 Dec; 21(46):13195-200. PubMed ID: 26675502
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of the recurrence pattern and risk factors for recurrence in patients with proximal gastric cancer who underwent curative gastrectomy.
Bilici A; Selcukbiricik F
Tumour Biol; 2015 Aug; 36(8):6191-9. PubMed ID: 25761877
[TBL] [Abstract][Full Text] [Related]
4. Is gastrectomy mandatory for all residual or recurrent gastric cancer following endoscopic resection? A large-scale Korean multi-center study.
Song KY; Hyung WJ; Kim HH; Han SU; Cho GS; Ryu SW; Lee HJ; Kim MC;
J Surg Oncol; 2008 Jul; 98(1):6-10. PubMed ID: 18521830
[TBL] [Abstract][Full Text] [Related]
5. Multiple gastric G1 neuroendocrine tumors with venous and lymphatic invasion.
Tatsuta T; Yoshimura T; Hasui K; Takasugi K; Sawaya M; Hanabata N; Shimoyama T; Kijima H; Fukuda S
Intern Med; 2013; 52(15):1697-701. PubMed ID: 23903502
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological features and outcome of type 3 gastric neuroendocrine tumours.
Min BH; Hong M; Lee JH; Rhee PL; Sohn TS; Kim S; Kim KM; Kim JJ
Br J Surg; 2018 Oct; 105(11):1480-1486. PubMed ID: 29893418
[TBL] [Abstract][Full Text] [Related]
7. Long-term results of endoscopic resection for type I gastric neuroendocrine tumors.
Uygun A; Kadayifci A; Polat Z; Yilmaz K; Gunal A; Demir H; Bagci S
J Surg Oncol; 2014 Feb; 109(2):71-4. PubMed ID: 24165913
[TBL] [Abstract][Full Text] [Related]
8. Management and disease outcome of type I gastric neuroendocrine tumors: the Mount Sinai experience.
Chen WC; Warner RR; Ward SC; Harpaz N; Divino CM; Itzkowitz SH; Kim MK
Dig Dis Sci; 2015 Apr; 60(4):996-1003. PubMed ID: 25399327
[TBL] [Abstract][Full Text] [Related]
9. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
Gincul R; Ponchon T; Napoleon B; Scoazec JY; Guillaud O; Saurin JC; Ciocirlan M; Lepilliez V; Pioche M; Lefort C; Adham M; Pialat J; Chayvialle JA; Walter T
Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
[No Abstract] [Full Text] [Related]
11. Patterns, timing and risk factors of recurrence of gastric cancer after laparoscopic gastrectomy: reliable results following long-term follow-up.
Nakagawa M; Kojima K; Inokuchi M; Kato K; Sugita H; Kawano T; Sugihara K
Eur J Surg Oncol; 2014 Oct; 40(10):1376-82. PubMed ID: 24915857
[TBL] [Abstract][Full Text] [Related]
12. Incidence of lymph node metastasis in intramucosal gastric cancer measuring 30 mm or less, with ulceration; mixed, predominantly differentiated-type histology; and no lymphovascular invasion: a multicenter retrospective study.
Takizawa K; Ono H; Yamamoto Y; Katai H; Hori S; Yano T; Umegaki E; Sasaki S; Iizuka T; Kawagoe K; Shimoda T; Muto M; Sasako M
Gastric Cancer; 2016 Oct; 19(4):1144-1148. PubMed ID: 26577295
[TBL] [Abstract][Full Text] [Related]
13. Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancer.
Jo MJ; Park JY; Song JS; Kook MC; Ryu KW; Cho SJ; Lee JH; Nam BH; Hong EK; Choi IJ; Kim YW
World J Gastroenterol; 2015 Jan; 21(2):667-74. PubMed ID: 25593497
[TBL] [Abstract][Full Text] [Related]
14. [Resection of local recurrent gastric cancer following total gastrectomy].
Matsuyama T; Izumi Y; Ito T; Tokita H; Iwao Y; Nishida K; Sakamoto K; Hosokawa T; Chika N; Kakimoto M; Park S; Yoshimura T; Koshiishi H; Okamura T
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2445-7. PubMed ID: 21224601
[TBL] [Abstract][Full Text] [Related]
15. [Neuroendocrine tumors of the stomach. Surgery therapy and prognosis].
Bektas H; Länger F; Piso P; Werner U; Musholt TJ; Lehner F; Becker T; Klempnauer J
Chirurg; 2002 Apr; 73(4):331-5. PubMed ID: 12063917
[TBL] [Abstract][Full Text] [Related]
16. [A 3mm Gastric Neuroendocrine Tumor That Metastasized to a Lymph Node].
Fukui Y; Kato Y; Okazaki Y; Kushitani Y; Kametani N; Tokumoto M; Yoshii M; Ako E; Yamada N; Nishimura S; Taenaka N
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1839-1841. PubMed ID: 30692371
[TBL] [Abstract][Full Text] [Related]
17. Additional gastrectomy after endoscopic mucosal resection for early gastric cancer.
Yajima H; Omura N; Takahashi N; Yoshida K; Yanaga K
Int Surg; 2015 Jan; 100(1):169-72. PubMed ID: 25594658
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of station-specific lymph node yield in laparoscopic and open distal gastrectomy for early gastric cancer.
Bouras G; Lee SW; Nomura E; Tokuhara T; Tsunemi S; Tanigawa N
Surg Laparosc Endosc Percutan Tech; 2011 Dec; 21(6):424-8. PubMed ID: 22146165
[TBL] [Abstract][Full Text] [Related]
19. Is endoscopic resection appropriate for type 3 gastric neuroendocrine tumors? Retrospective multicenter study.
Hirasawa T; Yamamoto N; Sano T
Dig Endosc; 2021 Mar; 33(3):408-417. PubMed ID: 32578248
[TBL] [Abstract][Full Text] [Related]
20. [Reoperation of recurrent gastric cancer--a comparative study of a resected and nonresected group].
Sunagawa M; Takeshita K; Nakajima A; Ochi K; Habu H; Hoshi K
Gan No Rinsho; 1984 Dec; 30(15):1899-903. PubMed ID: 6527408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
